In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

445 News Items found
Finding
A doctor examines a mole.
Don't Scratch That Mole? Scientists Are Learning More about Inflammation and Cancer

It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.
In the Lab
Illustration of how PU-PET localizes to tumors
Bull’s-Eye: Imaging Technology Could Confirm When a Drug Is Going to the Right Place

Collaborative team advances a new approach for imaging a drug that’s been developed to stop cancer growth.
Woman holding long-haired black cat.
Lung Cancer Caught Early: Marylou’s Story

A lifelong smoker overcomes discomfort over what a lung cancer imaging test might reveal. She hopes her experience helps reduce the stigma for others who smoke.
Gerstner Sloan Kettering Students
8 Gerstner Sloan Kettering Students Prepare To Graduate

Eight scientists are poised to receive their doctorates and embark on careers tackling problems in human disease through biomedical research. Their years of dedication and training will be recognized on May 18, 2022, when they will be awarded their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s commencement marks the school’s 11th graduating class since admitting its first students in 2006.
In the Lab
iron-filled macrophages from a breast cancer tumor
MSK-Developed Technology Provides a “Virtual Biopsy” of Immune Cells in Tumors

The noninvasive approach could help scientists track the movements of an important cell type that can influence the outcome of cancer treatment.
Perspective
Pictured: Craig Thompson
President Craig Thompson Reflects on 40-Year War on Cancer

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
In the Lab
Pictured: Timothy Chan
Investigators Sequence the Genome of a Rare Head and Neck Cancer

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.
SKI molecular biologist John Maciejowski
SKI Study Sheds Light on How a Natural Defense Against Viruses Can Lead to Mutations in Cancer Cells

A protein in the body that protects against viruses can also cause cancer-related mutations.
Support
Patient on left in chemotherapy infusion chair talking to nurse
The Unexpected Side Effects of Cancer Treatment

Learn about some lesser-known side effects from cancer treatment including falling caused by peripheral neuropathy, fatigue, hormone and sexual changes, and short-term memory problems (chemo brain).
In the Lab
An illustration of sugar being sprinkled on a cancer cell.
Just Add Sugar: How a Protein’s Small Change Leads to Big Trouble for Cells

A study from investigators in the Sloan Kettering Institute uncovers the details of how a key protein called GRP94 becomes disrupted, leading to cancer and other diseases.